WallStSmart

Core Laboratories NV (CLB)vsTechnipFMC PLC (FTI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

TechnipFMC PLC generates 1842% more annual revenue ($10.19B vs $524.73M). FTI leads profitability with a 10.6% profit margin vs 5.5%. CLB appears more attractively valued with a PEG of 1.44. FTI earns a higher WallStSmart Score of 64/100 (C+).

CLB

Hold

47

out of 100

Grade: D+

Growth: 2.7Profit: 5.0Value: 7.3Quality: 8.0
Piotroski: 4/9Altman Z: 2.36

FTI

Buy

64

out of 100

Grade: C+

Growth: 8.0Profit: 7.5Value: 3.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLBUndervalued (+65.9%)

Margin of Safety

+65.9%

Fair Value

$55.60

Current Price

$12.93

$42.67 discount

UndervaluedFair: $55.60Overvalued
FTISignificantly Overvalued (-81.9%)

Margin of Safety

-81.9%

Fair Value

$38.92

Current Price

$69.02

$30.10 premium

UndervaluedFair: $38.92Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLB2 strengths · Avg: 8.5/10
Debt/EquityHealth
0.159/10

Conservative balance sheet, low leverage

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

FTI2 strengths · Avg: 10.0/10
Return on EquityProfitability
32.2%10/10

Every $100 of equity generates 32 in profit

EPS GrowthGrowth
93.9%10/10

Earnings expanding 93.9% YoY

Areas to Watch

CLB4 concerns · Avg: 2.8/10
Market CapQuality
$629.68M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
5.5%3/10

5.5% margin — thin

Operating MarginProfitability
1.6%3/10

Operating margin of 1.6%

Revenue GrowthGrowth
-1.4%2/10

Revenue declined 1.4%

FTI4 concerns · Avg: 3.0/10
P/E RatioValuation
27.1x4/10

Moderate valuation

Price/BookValuation
8.2x4/10

Trading at 8.2x book value

PEG RatioValuation
2.592/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.182/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CLB

The strongest argument for CLB centers on Debt/Equity, Price/Book. PEG of 1.44 suggests the stock is reasonably priced for its growth.

Bull Case : FTI

The strongest argument for FTI centers on Return on Equity, EPS Growth. Revenue growth of 11.6% demonstrates continued momentum.

Bear Case : CLB

The primary concerns for CLB are Market Cap, Profit Margin, Operating Margin.

Bear Case : FTI

The primary concerns for FTI are P/E Ratio, Price/Book, PEG Ratio.

Key Dynamics to Monitor

CLB carries more volatility with a beta of 0.99 — expect wider price swings.

FTI is growing revenue faster at 11.6% — sustainability is the question.

FTI generates stronger free cash flow (277M), providing more financial flexibility.

Monitor OIL & GAS EQUIPMENT & SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

FTI scores higher overall (64/100 vs 47/100) and 11.6% revenue growth. CLB offers better value entry with a 65.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Core Laboratories NV

ENERGY · OIL & GAS EQUIPMENT & SERVICES · USA

Core Laboratories NV (CLB) is a premier provider of specialized reservoir optimization services and products within the oil and gas sector, dedicated to enhancing reservoir characterization and production efficiency. The company employs advanced technologies and proprietary analytics to deliver innovative solutions while maintaining a strong commitment to sustainability. With a robust global footprint, Core Labs is strategically positioned to capitalize on new growth opportunities and adeptly address the evolving challenges in the dynamic energy landscape.

Visit Website →

TechnipFMC PLC

ENERGY · OIL & GAS EQUIPMENT & SERVICES · USA

TechnipFMC plc is involved in oil and gas projects, technologies, systems and services. The company is headquartered in London, the United Kingdom.

Want to dig deeper into these stocks?